52 related articles for article (PubMed ID: 32049866)
1. The outcome of primary tumor resection in the unresectable stage IV colorectal cancer patients who received the bevacizumab-containing chemotherapy.
Yeom SS; Lee SY; Kwak HD; Kim CH; Kim YJ; Kim HR
Medicine (Baltimore); 2020 Feb; 99(7):e19258. PubMed ID: 32049866
[TBL] [Abstract][Full Text] [Related]
2. The impact of primary tumor resection for asymptomatic colorectal cancer patients with unresectable metastases: a systematic review and meta-analysis.
Li S; Ji L; Huang J; Wang Y; Liu P; Zhang W; Lou Z
Int J Colorectal Dis; 2023 Aug; 38(1):214. PubMed ID: 37581775
[TBL] [Abstract][Full Text] [Related]
3. Palliative primary tumor resection may not offer survival benefits for patients with unresectable metastatic colorectal neuroendocrine neoplasms, one multicenter retrospective cohort study.
Yu G; Liu S; Wang Z; Liu Q; Ren H; Hu W
BMC Surg; 2024 Mar; 24(1):85. PubMed ID: 38475759
[TBL] [Abstract][Full Text] [Related]
4. Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV Trials.
Rahbari NN; Biondo S; Frago R; Feißt M; Kreisler E; Rossion I; Serrano M; Jäger D; Lehmann M; Sommer F; Dignass A; Bolling C; Vogel I; Bork U; Büchler MW; Folprecht G; Kieser M; Lordick F; Weitz J;
J Clin Oncol; 2024 May; 42(13):1531-1541. PubMed ID: 38412408
[TBL] [Abstract][Full Text] [Related]
5. Palliative primary tumor resection provides survival benefits for the patients with metastatic colorectal cancer and low circulating levels of dehydrogenase and carcinoembryonic antigen.
He WZ; Rong YM; Jiang C; Liao FX; Yin CX; Guo GF; Qiu HJ; Zhang B; Xia LP
Chin J Cancer; 2016 Jun; 35(1):58. PubMed ID: 27357402
[TBL] [Abstract][Full Text] [Related]
6. Palliative resection of the primary tumour improves survival in incurable metastatic colorectal cancer.
Inci K; Nilsson B; Lindskog S; Giglio D
ANZ J Surg; 2023 Nov; 93(11):2680-2685. PubMed ID: 37489624
[TBL] [Abstract][Full Text] [Related]
7. Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?
Ergun Y; Bal O; Dogan M; Ucar G; Dirikoc M; Acikgoz Y; Bacaksiz F; Uncu D
J Res Med Sci; 2020; 25():14. PubMed ID: 32174986
[TBL] [Abstract][Full Text] [Related]
8. Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies.
Fanotto V; Rossini D; Casagrande M; Bergamo F; Spagnoletti A; Santini D; Antoniotti C; Cupini S; Daniel F; Nasca V; Vetere G; Zaniboni A; Borelli B; Carullo M; Conca V; Passardi A; Tamburini E; Masi G; Pella N; Cremolini C
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001711
[TBL] [Abstract][Full Text] [Related]
9. The Real-Life Impact of Primary Tumor Resection of Synchronous Metastatic Colorectal Cancer-From a Clinical Oncologic Point of View.
Pécsi B; Mangel LC
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672540
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes of Upfront Primary Tumor Resection in Synchronous Unresectable Metastatic Colorectal Cancer.
Shin JE; An HJ; Shim BY; Kim H; Park HS; Cho HM; Kye BH; Yoo RN; Moon JY; Kim SH; Lee J; Lee HC; Jung JH; Lee KM; Lee JM
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894424
[TBL] [Abstract][Full Text] [Related]
11. Left-sided primary tumor is a favorable prognostic factor for metastatic colorectal cancer patients receiving surgery.
Li XF; Tan YN; Zhong CH; Zhu LZ; Fang XF; Li J; Ding KF; Yuan Y
Oncotarget; 2017 Oct; 8(45):79618-79628. PubMed ID: 29108341
[TBL] [Abstract][Full Text] [Related]
12. Upfront primary tumor resection versus upfront systemic therapy for metastatic colorectal cancer: a systematic review and meta-analysis.
Lo SJ; Huang SH; Lai IL; Chern YJ; Hsu YJ; Liao CK; Cheng CC; Tsai WS; Hsieh PS; You JF
Int J Colorectal Dis; 2023 Jul; 38(1):186. PubMed ID: 37405554
[TBL] [Abstract][Full Text] [Related]
13. Assessing the effectiveness of targeted agents in adjuvant therapy for patients with metastatic colorectal cancer undergoing surgical resection: a retrospective cohort study.
Su YC; Wu CC; Chen YH; Su CC; Chang YC; Hsieh MC; Kao Yang YH
Ther Adv Med Oncol; 2024; 16():17588359241246427. PubMed ID: 38655393
[TBL] [Abstract][Full Text] [Related]
14. Role of Surgical Approach to Synchronous Colorectal Liver Metastases: A Retrospective Analysis.
Zhai S; Sun X; Du L; Chen K; Zhang S; Shi Y; Yuan F
Cancer Manag Res; 2021; 13():3699-3711. PubMed ID: 33994810
[TBL] [Abstract][Full Text] [Related]
15. Predicting surgical benefit of primary tumor resection in patients with stage IV colorectal cancer.
Yang Y; Lam W; Lyu Z; Ouyang K; Chen R; Wang J; Wu D; Yang Z; Li Y
Asian J Surg; 2024 Apr; ():. PubMed ID: 38609833
[TBL] [Abstract][Full Text] [Related]
16. Primary tumor resection in colorectal cancer with unresectable synchronous metastases: A review.
de Mestier L; Manceau G; Neuzillet C; Bachet JB; Spano JP; Kianmanesh R; Vaillant JC; Bouché O; Hannoun L; Karoui M
World J Gastrointest Oncol; 2014 Jun; 6(6):156-69. PubMed ID: 24936226
[TBL] [Abstract][Full Text] [Related]
17. Response of the primary tumor in symptomatic and asymptomatic stage IV colorectal cancer to combined interventional endoscopy and palliative chemotherapy.
Cameron S; Hünerbein D; Mansuroglu T; Armbrust T; Scharf JG; Schwörer H; Füzesi L; Ramadori G
BMC Cancer; 2009 Jul; 9():218. PubMed ID: 19570230
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of patients in their forties who underwent surgical resection for colorectal cancer in Korea.
Lee CS; Baek SJ; Kwak JM; Kim J; Kim SH
World J Gastroenterol; 2021 Jul; 27(25):3901-3912. PubMed ID: 34321853
[TBL] [Abstract][Full Text] [Related]
19. Primary tumor resection improves prognosis of unresectable carcinomas of the transverse colon including flexures with pulmonary metastasis: a cohort study.
Zhao H; Song G; Wang R; Guan N; Yun C; Yang J; Ma JB; Li H; Xiao W; Peng L
Eur J Cancer Prev; 2024 Mar; 33(2):95-104. PubMed ID: 37823436
[TBL] [Abstract][Full Text] [Related]
20. FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial.
Heinemann V; von Weikersthal LF; Decker T; Kiani A; Kaiser F; Al-Batran SE; Heintges T; Lerchenmüller C; Kahl C; Seipelt G; Kullmann F; Moehler M; Scheithauer W; Held S; Miller-Phillips L; Modest DP; Jung A; Kirchner T; Stintzing S
Br J Cancer; 2021 Feb; 124(3):587-594. PubMed ID: 33154570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
